Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS)

45 filings reported holding TARS - Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q1 2021.
Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 12,761,893 shares of 42,194,093 outstanding shares and own 30.2% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (3,245,035 shares), RTW INVESTMENTS, LP (2,463,601 shares), FRAZIER MANAGEMENT LLC (1,917,157 shares), Cormorant Asset Management, LP (1,714,269 shares), PERCEPTIVE ADVISORS LLC (1,296,416 shares), TimesSquare Capital Management, LLC (451,900 shares), BlackRock Inc. (339,797 shares), VANGUARD GROUP INC (272,990 shares), SANDS CAPITAL MANAGEMENT, LLC (260,000 shares), and Ensign Peak Advisors, Inc (200,000 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.